Literature DB >> 4990023

In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.

C B Smith, J N Wilfert, P E Dans, T A Kurrus, M Finland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4990023     DOI: 10.1093/infdis/122.supplement_1.s14

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function.

Authors:  G R Aronoff; R A Brier; R S Sloan; M E Brier
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Alternative strategies for proof-of-principle studies of antibacterial agents.

Authors:  Axel Dalhoff; Andrej Weintraub; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.

Authors:  D C Blair; D O Duggan; E T Schroeder
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

4.  Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.

Authors:  C E Lopez; H C Standiford; B A Tatem; F M Calia; S C Schimpff; M J Snyder; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

5.  Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.

Authors:  G L Simon; D R Snydman; F P Tally; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

6.  Comparison of gentamicin, carbenicillin and gentamicin, and carbenicillin in Pseudomonas sepsis in monkeys.

Authors:  S Saslaw; H N Carlisle; M Moheimani
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.